These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combined action of ribovirin and rimantadine in experimental myxovirus infection. Galegov GA; Pushkarskaya NL; Obrosova-Serova NP; Zhdanov VM Experientia; 1977 Jul; 33(7):905-6. PubMed ID: 891769 [No Abstract] [Full Text] [Related]
7. [Comparative study of the anti-influenzal effectiveness of bonafton, oxoline, florenal and rimantadine]. Zastavnyĭ IV Mikrobiol Zh (1978); 1979; 41(1):69-74. PubMed ID: 440154 [No Abstract] [Full Text] [Related]
8. Anti-influenza A activity of some N-substituted bicyclo[3.2.1]octane-3-spiro-3'-pyrrolidine hydrochlorides: synthesis and structure. de la Cuesta E; Ballesteros P; Trigo GG J Pharm Sci; 1984 Sep; 73(9):1307-9. PubMed ID: 6491959 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis and in vitro virucidal effect of recent 1-substituted adamantane derivatives]. Sztaricskai F; Pelyvás I; Dinya Z; Szilágyi L; Györgydeák Z; Hadházy G; Váczi L; Bognár R Pharmazie; 1975 Sep; 30(9):571-81. PubMed ID: 1187737 [No Abstract] [Full Text] [Related]
10. [Comparative study of the antiviral activity of rimantadine and bonafton]. Il'enko VI; Platonov VG; Khomenkova IK Vopr Virusol; 1977; (2):223-8. PubMed ID: 898899 [TBL] [Abstract][Full Text] [Related]
11. Animal models for evaluation of compounds against influenza viruses. Boyd MR; Beeson MF J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):43-7. PubMed ID: 1206030 [No Abstract] [Full Text] [Related]
12. Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine. Aldrich PE; Hermann EC; Meier WE; Paulshock M; Prichard WW; Snyder JA; Watts JC J Med Chem; 1971 Jun; 14(6):535-43. PubMed ID: 5091970 [No Abstract] [Full Text] [Related]
13. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313 [TBL] [Abstract][Full Text] [Related]
15. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine]. Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040 [TBL] [Abstract][Full Text] [Related]
16. Aerosol therapy of influenza infections of mice and primates with rimantadine, ribavirin, and related compounds. Stephen EL; Walker JS; Dominik JW; Young HW; Berendt RF Ann N Y Acad Sci; 1977 Mar; 284():264-71. PubMed ID: 101109 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of some adamantane derivatives of 2-aminobenzothiazoles. Costakis E; Canonne P J Med Chem; 1971 Dec; 14(12):1222-3. PubMed ID: 5116240 [No Abstract] [Full Text] [Related]
18. General synthesis of potentially antiviral alpha-adamantyl carbonyl compounds. Reetz MT; Maier WF; Schwellnus K; Chatziiosifidis I Angew Chem Int Ed Engl; 1979 Jan; 18(1):72. PubMed ID: 105650 [No Abstract] [Full Text] [Related]
19. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity. Zoidis G; Kolocouris N; Naesens L; De Clercq E Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900 [TBL] [Abstract][Full Text] [Related]
20. [Syntheses of aminoacid derivatives and their biological activities. I. Anti-influenza activity (author's transl)]. Kanao S; Toyoda T; Suyama T; Toyoshima S Yakugaku Zasshi; 1975 Apr; 95(4):397-401. PubMed ID: 1171957 [No Abstract] [Full Text] [Related] [Next] [New Search]